Axovant Sciences announces expansion of dementia pipeline
HAMILTON, BERMUDA: Axovant Sciences Ltd. (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the…
FEATURED
New drug hope for ‘childhood Alzheimer’s’ after global trials
Charity now set to build new pods for homeless people
Lilly’s Alzheimer’s super drug to be approved ‘any day’
Pensioner with ‘severe dementia’ living in care home is prosecuted
Inquest begins after man took wife’s end-of-life medication
Surveys show public support on euthanasia for mentally ill
INNOVATION
